Janet Diaz-Martinez

Dr. Janet Diaz-Martinez

Florida International University, Miami, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2021 in AIDS and Behavior
Verified
Journal Article
Closed access
PDF file
JDJanet Diaz-Martinez
Janet Diaz-Martinez
JTJavier A. Tamargo
Javier A. Tamargo
Ivan Delgado-EncisoIvan Delgado-Enciso
Ivan Delgado-Enciso
QLQingyun Liu
Qingyun Liu
LALeonardo Acuña
Leonardo Acuña
MBMarianna Karas Baum
Marianna Karas Baum

14 May 2019 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
JDJanet Diaz-Martinez
Janet Diaz-Martinez
ACAdriana Campa
Adriana Campa
Ivan Delgado-EncisoIvan Delgado-Enciso
Ivan Delgado-Enciso
DHDebra Hain
Debra Hain
FGFlorence George
Florence George
MBMarianna Baum
Marianna Baum

24 February 2021 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
JTJavier A. Tamargo
Javier A. Tamargo
HFHaley Raine Fonseca
Haley Raine Fonseca
JDJanet Diaz-Martinez
Janet Diaz-Martinez
MTMary Jo Trepka
Mary Jo Trepka
Ivan Delgado-EncisoIvan Delgado-Enciso
Ivan Delgado-Enciso
MBMarianna Karas Baum
Marianna Karas Baum
Background: Socioeconomic disadvantages and potential immunocompromise raise particular concerns for people living with HIV (PLWH) and other marginalized communities during the COVID-19 pandemic. In this study, we explored COVID-19 testing and the impact of the pandemic among participants from the Miami Adult Studies on HIV cohort, predominantly composed of low-income minorities living with and without HIV. Methods: Between July and August 2020, a telephone survey was administered to 299 Miami Adult Studies on HIV participants to assess COVID-19 testing, prevention behaviors, and psychosocial stressors. Health care utilization, antiretroviral adherence, food insecurity, and substance use during the pandemic were compared with those of their last cohort visit (7.8 ± 2.9 months earlier). Results: Half of surveyed participants had been tested for COVID-19, 8 had tested positive and 2 had been hospitalized. PLWH (n = 183) were 42% times less likely than HIV-uninfected participants to have been tested. However, after adjustment for age, employment, COVID-19 symptoms, mental health care, and substance use, the effect of HIV status was no longer significant. PLWH were more likely to have seen a health care provider, use face coverings, and avoid public transportation and less likely to be food insecure and drink hazardously. There were significant changes in substance use patterns during the pandemic when compared with those before. Conclusion: PLWH, compared with their HIV-uninfected peers, were more likely to engage in preventive measures and health care during the pandemic, potentially reducing their exposure to COVID-19. There were no reported changes in antiretroviral adherence or health care utilization, but there were changes in substance use; these need to be monitored as this crisis progresses.

25 March 2025 in Medicina
Verified
Journal Article
Open access
PDF file
JVJesús Venegas-Ramìrez
Jesús Venegas-Ramìrez
Gustavo A. Hernandez-FuentesGustavo A. Hernandez-Fuentes
Gustavo A. Hernandez-Fuentes
CPClaudia S. Palomares
Claudia S. Palomares
JDJanet Diaz-Martinez
Janet Diaz-Martinez
RGRosa M González
Rosa M González
Ivan Delgado-EncisoIvan Delgado-Enciso
Ivan Delgado-Enciso
Background and Objectives: Arteriovenous fistulas (AVFs) are the preferred vascular access for hemodialysis due to their impact on patient outcomes, including survival, infection rates, and overall quality of life. Despite strong recommendations favoring AVF, gaps in AVF utilization remain, influenced by clinical, demographic, and systemic factors. This study is the first to analyze survival outcomes associated with different dialysis vascular access types, adjusting for key clinical, demographic variables, and other comorbidities over extended periods. Materials and Methods: This ambispective cohort study followed 428 hemodialysis patients over seven years. Patients were categorized based on their access type: AVF (n = 189), tunneled central venous catheter (CVC) (n = 178), and non-tunneled CVC (n = 61). Kaplan–Meier survival analysis was used to estimate survival curves, and Cox proportional hazards regression adjusted for potential confounders, including age, diabetes, and hypertension. Results: The 2-year survival rates were as follows: AVF 94.1%, tunneled CVC 70.0%, and non-tunneled CVC 36.6%. The 7-year survival rates were as follows: AVF 65.5%, tunneled CVC 26.4%, and non-tunneled CVC 11.0%. Compared to AVF, tunneled CVC use was associated with a 2.8-fold increased risk of mortality (adjusted hazard ratio [AdHR] 2.8, 95% CI 2.0–4.1), while non-tunneled CVC increased the risk 5-fold (AdHR 5.0, 95% CI 3.3–7.6). Notably, older adults, women, and diabetic patients were disproportionately represented in the groups with tunneled and non-tunneled catheters. Conclusions: Adjusted survival analyses highlight the significantly lower survival rates associated with CVC use compared to AVF. Non-tunneled catheters are generally not used for prolonged periods, and this cohort provides evidence of their prognosis for long-term use. These findings reinforce the need to prioritize AVF placement whenever feasible, reinforcing health education on this topic, to improve long-term outcomes for hemodialysis patients.

27 November 2024 in Diseases
Verified
Journal Article
Open access
PDF file
Gustavo A. Hernandez-FuentesGustavo A. Hernandez-Fuentes
Gustavo A. Hernandez-Fuentes
JRJessica C. Romero-Michel
Jessica C. Romero-Michel
VGVeronica M. Guzman-Sandoval
Veronica M. Guzman-Sandoval
JDJanet Diaz-Martinez
Janet Diaz-Martinez
DDDelgado-Enciso Delgado-Enciso
Delgado-Enciso Delgado-Enciso
Ivan Delgado-EncisoIvan Delgado-Enciso
Ivan Delgado-Enciso
Background: The COVID-19 pandemic significantly impacted mental health and substance use patterns, particularly among young adults. Objective: This study aimed to assess changes in anxiety, depression, self-esteem, and substance use among university students in Mexico before, during, and after the pandemic. Methods: Using a repeated cross-sectional design, this study was conducted with university students in Mexico across three periods: pre-pandemic (2017 and 2019); during the pandemic (2021); and post-pandemic (2023). A total of 2167 students were interviewed during one of the three periods. Standardized scales measured anxiety, depression, self-esteem, Erotic Response and Sexual Orientation Scale (EROS), and substance use. Results: showed a marked and significant increase in the proportion of students with anxiety (40.0%, 71.7%, and 79.6%) and depression (14.4%, 61.9%, and 62.6%) during the pre-pandemic, pandemic, and post-pandemic periods, respectively. Self-esteem significantly decreased during and after the pandemic, compared to pre-pandemic, particularly among females. The proportion of students categorized as moderate/high-risk for their substance use changed over time, showing a reduction in alcohol use (from 29.9% to 20.2%) and tobacco use (from 26.0% to 18.2%) but an increase in sedative use (from 7.1% to 11.7%), before vs after the pandemic, respectively. Multivariate analysis revealed that anxiety, low self-esteem, and increased sedative use were consistently linked to a heightened risk of depression during and after the pandemic. Notably, anxiety and depression levels remained in a proportion significantly elevated even in the post-pandemic period. Conclusions: These findings underscore the enduring impact of the COVID-19 pandemic on the mental health of university students, highlighting the urgent need for targeted interventions, early detection strategies, and customized educational programs to effectively support students’ mental well-being in the ongoing post-pandemic era.

23 December 2024 in Life
Verified
Journal Article
Open access
PDF file
Gustavo A. Hernandez-FuentesGustavo A. Hernandez-Fuentes
Gustavo A. Hernandez-Fuentes
DDDelgado-Enciso Delgado-Enciso
Delgado-Enciso Delgado-Enciso
ELEdgar G. Larios-Cedeño
Edgar G. Larios-Cedeño
JSJuan M. Sánchez-Galindo
Juan M. Sánchez-Galindo
SCSilvia G. Ceballos-Magaña
Silvia G. Ceballos-Magaña
Ivan Delgado-EncisoIvan Delgado-Enciso
Ivan Delgado-Enciso
Background: Annona muricata L. (guanabana) leaves are rich in bioactive compounds with potential antioxidant properties. In the state of Colima, both ethanolic extracts and infusions are traditionally used in folk medicine to address various ailments. This study aimed to evaluate and compare the phytochemical composition and antioxidant activities of ethanolic extracts and infusions of A. muricata leaves from three geographic regions in Colima, Mexico, with a focus on how geographic origin affects their bioactive properties. Methods: Ethanolic extracts and infusions were prepared from A. muricata leaves and analyzed using phytochemical screening; DPPH, total antioxidant capacity (TAC), and total phenolic content (TPC) measurements; and HPLC. TLC was also conducted to examine the presence of specific compounds, such as flavonoids and phenols. Results: Both the ethanolic extracts and infusions contained significant levels of alkaloids, flavonoids, tannins, and phenolic compounds. The infusions demonstrated superior antioxidant capacity, with DPPH inhibition values of 72.5%, 68.3%, and 65.1% in the northern, central, and southern regions, respectively, compared to the ethanolic extracts’ values of 50.3%, 48.9%, and 45.0%. HPLC identified quercetin as a major compound across all samples. Geographically, the northern region exhibited higher concentrations of bioactive compounds, particularly total flavonoid content (TFC) and iron-reducing power (FRPA). Conclusions: Both the ethanolic extracts and infusions of A. muricata leaves exhibited significant antioxidant properties, with the infusions showing superior performance. The results suggest that A. muricata infusions may have potential applications in managing oxidative stress-related diseases such as cancer and diabetes. Exploring their use in traditional medicine and employing this type of approach can help discern the metabolite profile responsible for these bioactivities. Geographic factors influence the bioactive profile of the plant, and further research is needed to isolate specific bioactive compounds and elucidate their therapeutic mechanisms.